Cellular signaling events in the pathogenesis of arterial stiffening: an approach to identify Cbfa1 (core binding factor alpha1) as a key mediator of vascular remodeling
Cellular signaling events in the pathogenesis of arterial stiffening: an approach to identify Cbfa1 (core binding factor alpha1) as a key mediator of vascular remodeling
批准号:
209947703
负责人:
Privatdozent Dr. Uwe Raaz
金额:
$0.0万
依托单位国家:
德国
项目类别:
Research Fellowships
财政年份:
2011
资助国家:
德国
项目状态:
已结题
起止时间:
2010-12-31 至 2012-12-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Arterial stiffening is associated with ageing and numerous disease states such as hypertension, congestive heart failure, diabetes mellitus or renal failure. Here arterial stiffness may represent a central pathophysiologic factor that alters/impairs macro- and microcirculation resulting in disease progression. In accordance increased arterial stiffness has been identified as an independent risk factor for cardiovascular disease. Consequently modulation of arterial stiffness represents an attractive therapeutic target for a plenty of diseases. However, effective therapies that target the structural abnormalities and changes in vascular signaling that underlie the process of stiffening are currently lacking.Vascular remodeling (i.e. the structural correlate of arterial stiffening) comes along with an altered pattern of gene expression and activation of specific cellular signaling pathways. Preliminary data indicate a critical role of the transcription factor, core binding factor alpha1 (Cbfa1) as a mediator of arterial stiffening.This project is based on the assumption that Cbfa1 is a universal regulator of vascular fibrosis and arterial stiffening. The aim of this project therefore is to test the hypotheses that 1) arterial Cbfa1 expression is commonly induced by diverse triggers of vascular stiffening (e.g., mechanical stress, hormones as angiotensin II or insulin, glucose, etc.), 2) enhanced Cbfa1 activity, per se, results in increased vascular stiffness and finally 3) Cbfa1 is a critical mediator in differentially induced processes of arterial stiffening. In a more general approach apart from Cbfa1 expression 4) further universal signaling events in arterial stiffness shall be identified.The results of the present project elucidate a novel mechanism that may underlie arterial stiffening (Cbfa1 signaling; hypotheses 1-3) and moreover may identify further potential targets for therapeutic intervention (hypothesis 4).
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
登录
查看更多内容
Foxc2介导Syap1/Akt信号通路调控破骨/成骨细胞分化促进颞下颌关节骨关节炎的机制研究
-
批准号:82370979
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:张善勇
-
依托单位:
丁酸梭菌代谢物(如丁酸、苯乳酸)通过MYC-TYMS信号轴影响结直肠癌化疗敏感性的效应及其机制研究
-
批准号:82373139
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:李孟鸿
-
依托单位:
PROCR信号通路介导的血管新生在卵巢组织移植中的作用及机制研究
-
批准号:82371726
-
项目类别:面上项目
-
资助金额:50.00万元
-
批准年份:2023
-
负责人:李文
-
依托单位:
GREB1突变介导雌激素受体信号通路导致深部浸润型子宫内膜异位症的分子遗传机制研究
-
批准号:82371652
-
项目类别:面上项目
-
资助金额:45.00万元
-
批准年份:2023
-
负责人:刘开江
-
依托单位:
GASP-1通过Myostatin信号通路调控颏舌肌功能的作用及机制研究
-
批准号:82371131
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:易红良
-
依托单位:
运用3D打印和生物反应器构建仿生尿道模型探索Hippo-YAP信号通路调控尿道损伤修复的机制研究
-
批准号:82370684
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:傅强
-
依托单位:
“肠—肝轴”PPARα/CYP8B1胆汁酸合成信号通路在减重手术改善糖脂代谢中的作用与机制
-
批准号:82370902
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:田景琰
-
依托单位:
PCBP1和PCBP2调控cGAS的相变和酶活的机制研究
-
批准号:32370928
-
项目类别:面上项目
-
资助金额:50.00万元
-
批准年份:2023
-
负责人:孙钦秒
-
依托单位:
组蛋白乙酰化修饰ATG13激活自噬在牵张应力介导骨缝Gli1+干细胞成骨中的机制研究
-
批准号:82370988
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:经典
-
依托单位:
蛋白精氨酸甲基化转移酶PRMT5调控PPARG促进巨噬细胞M2极化及其在肿瘤中作用的机制研究
-
批准号:82371738
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:郑英霞
-
依托单位: